Tag: Astrazeneca

AstraZeneca: new president for France

(CercleFinance.com) – AstraZeneca announces the appointment of Anne-Laure Dreno as President France from July 1, thus succeeding Olivier Nataf in a context where the group aims to launch 15 new…

AstraZeneca: FDA recommends nirsevimab for RSV

Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…

AstraZeneca: the Koselugo has been approved in China

(CercleFinance.com) – AstraZeneca announced on Monday that the Chinese Medicines Agency had approved Koselugo, developed as part of its partnership with the American Merck, for the treatment of neurofibromatosis type…

AstraZeneca: positive results in lung cancer

(CercleFinance.com) – AstraZeneca announced on Monday that a treatment based on Imfinzi had been shown to be effective in patients suffering from an operable type of lung cancer. The combination…

AstraZeneca: First approval in China for Enhertu

Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…

AstraZeneca: New data coming in the VRS

Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…

AstraZeneca posts sharply higher profit

By Le Figaro with AFP Published on 02/09/2023 at 10:23, Update on 02/09/2023 at 12:06 The group’s share of profit amounted to 3.3 billion dollars against 112 million a year…

AstraZeneca: Stifel lowers target, cautious for 2023

(CercleFinance.com) – Stifel maintains its ‘buy’ recommendation on AstraZeneca stock, but reduces its price target on the stock from 13,300p to 12,800p. While the laboratory will present its 2022 annual…